EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phage PM16 Therapy Induce Long-Term Protective Immunity Against Proteus mirabilis via Macrophage Priming

Lina Al Allaf iD, Anton V Chechushkov iD, Vera V Morozova iD, Yulia N Kozlova iD, Tatiana A Ushakova, Nina V Tikunova iD

Pathogens · 2026

DOI: 10.3390/pathogens15010099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2026. Verfasst von Lina Al Allaf und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Microbiology, Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, Novosib…. Hauptthemen laut MEDLINE: Proteus mirabilis, Macrophages, Proteus Infections, Phage Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Ministry of Education and Science of Russia, Russian Scientific Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacteriophages, traditionally viewed solely as antibacterial agents, are increasingly being studied for their immunomodulatory properties. In this study, we demonstrate that PM16 phage therapy not only effectively controls subcutaneous Proteus mirabilis infection in mice but also induces long-term specific humoral immunity against subsequent reinfection. This immunomodulatory effect was dose-dependent. In vitro, PM16 directly activates macrophages, leading to increased production of proinflammatory cytokines (tumor necrosis factor-α and interleukin-1β) and inducible nitric oxide synthase, and enhances macrophage bactericidal activity against P. mirabilis. We assume that the enhancement of the adaptive immune response is mediated not by the phage acting as a classical antigenic adjuvant but by its ability to prime innate immune cells, specifically macrophages. This priming leads to more efficient bacterial clearance, antigen presentation, and the formation of protective immunological memory.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proteus mirabilisMacrophagesProteus InfectionsPhage TherapyBacteriophagesAnimalsMiceCytokinesImmunity, HumoralFemale

Stichwörter der Autor:innen

PM16Proteus mirabilisbacteriophagecytokineshumoral immunitymacrophagephage therapy

Substanzen

Cytokines

Autor:innen und Institutionen

  • Laboratory of Molecular Microbiology, Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, Novosibirsk 630090, Russia.

ORCID-Profile: Lina Al Allaf, Anton V Chechushkov, Vera V Morozova, Yulia N Kozlova, Nina V Tikunova

Förderung

  • Russian Science Foundation
  • Ministry of Education and Science of Russia
  • Russian Scientific Foundation
  • Ministry of Education and Science

Zitieren

APA

Al Allaf, L., Chechushkov, A. V., Morozova, V. V., Kozlova, Y. N., Ushakova, T. A., & Tikunova, N. V. (2026). Phage PM16 Therapy Induce Long-Term Protective Immunity Against Proteus mirabilis via Macrophage Priming. Pathogens. https://doi.org/10.3390/pathogens15010099

Vancouver

Al Allaf L, Chechushkov AV, Morozova VV, Kozlova YN, Ushakova TA, Tikunova NV. Phage PM16 Therapy Induce Long-Term Protective Immunity Against Proteus mirabilis via Macrophage Priming. Pathogens. 2026. doi:10.3390/pathogens15010099

BibTeX
@article{AlAllaf2026,
  author = {Al Allaf, Lina and Chechushkov, Anton V and Morozova, Vera V and Kozlova, Yulia N and Ushakova, Tatiana A and Tikunova, Nina V},
  title = {Phage PM16 Therapy Induce Long-Term Protective Immunity Against Proteus mirabilis via Macrophage Priming},
  journal = {Pathogens},
  year = {2026},
  doi = {10.3390/pathogens15010099}
}
Kostenlos starten →